驾驭试验中的重重考验:ProRIDE试验在非洲农村地区招募、保留和随访的经验教训
ProRIDE随机临床试验于2022年2月开始招募,在11个月内成功入组2000名婴儿,6月龄时随访率达97%。本文叙述了研究方案的关键组成部分、研究团队构成、社区动员工作及研究的地方执行情况,并总结在低收入农村地区开展儿科试验的经验。
要点
- ProRIDE试验在11个月内入组2000名婴儿,6月龄随访率达97%。
- 照护者在家中给药以模拟真实世界治疗实践,第7天家访确认给药正确性并重申指导。
- 研究启动前与挪威、坦桑尼亚机构及医院领导层合作,重点加强实验室基础设施和血培养技术培训。
核心结论
- 尽管试验前和试验期间面临诸多挑战,该随机临床试验在11个月内成功招募2000名参与者,归因于整个过程中展现的强有力合作与团队协作。
- 作者认为试验成功完成的关键因素之一是有意设计简单、直接且实用的干预措施和研究框架。
- 从本研究中获得的见解可能对旨在低收入环境中开展婴儿和儿童研究的研究人员和科学家特别有意义。
研究设计与样本
- ProRIDE随机临床试验于2022年2月开始招募参与者,在11个月期间成功入组2000名婴儿,6月龄时随访率达97%。
- 本文为叙述性文章,描述研究方案的关键组成部分、研究团队构成、社区动员工作以及研究的地方执行情况。
- 研究由高收入国家和低收入国家的科学家合作组构思,在坦桑尼亚农村低收入社区实施。
- 该试验在ClinicalTrials.gov注册,注册号NCT04172012,注册日期2019年11月21日。
主要发现
- 研究团队基于既往在坦桑尼亚的研究发现(一致表明与多重耐药菌相关的严重感染高流行),认识到亟需旨在降低脓毒症和严重细菌感染发病率的预防策略。
- 照护者在家中给予研究药物,从而模拟真实世界治疗实践并增强研究结果的普适性。
- 为确保对一个月干预方案的依从性,研究团队在第7天进行家访,确认研究产品的正确给药并解决相关的早期挑战;家访期间现场工作人员重申正确使用产品的说明。
- 研究启动前进行了周密的规划阶段,涉及挪威、坦桑尼亚Muhimbili健康与相关科学大学以及Haydom Lutheran Hospital领导层之间的广泛合作。
- 通过一系列会议和讨论,挪威和坦桑尼亚的研究团队确定了需要加强的具体领域,特别是实验室基础设施以及人员在血培养技术和抗菌药物敏感性试验方面的培训。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ProRIDE randomized clinical trial (RCT) started participant recruitment in February 2022, successfully enrolling 2,000 infants within an 11-month period and achieving a follow-up rate of 97% at six months of age. This narrative article describes critical components of the research protocol, the composition of the research team, community sensitization efforts, and the local performance of the study. The research initiative was conceptualized by a collaborative group of scientists from both high- and low-income countries, and its successful implementation was contingent upon the active involvement and participation of a rural, low-income community. Based on previous study findings in Tanzania, which consistently indicated a high prevalence of severe infections related to multidrug-resistant bacteria, the research team recognized the urgent need for preventive strategies aimed at reducing the incidence of sepsis and severe bacterial infections. Given the scarcity of data from rural areas and the imperative for inclusivity, the rationale for conducting this RCT in a rural context was compelling. We believe that a key factor in the successful completion of this trial was the intentional design of a simple, straightforward, and practical intervention, and study framework. Caregivers administered the study medication at home, thereby mirroring real-world therapeutic practices and enhancing the generalizability of the findings. To ensure adherence to the one-month intervention regimen, the research team conducted a day-seven home visit to confirm proper administration of the investigational product and address any associated early challenges. During this interaction, the field workers reiterated the instructions for the proper application of the product, thereby serving as a reminder to the caretaker regarding its correct usage. Additionally, a thorough planning phase was undertaken prior to the study's commencement, involving extensive collaboration between the researchers from Norway, Muhimbili University of Health and Allied Sciences, Tanzania, and the leadership at Haydom Lutheran Hospital. Through a series of meetings and discussions, the research team in Norway and Tanzania identified specific areas requiring enhancement, particularly in laboratory infrastructure and the training of personnel in blood culture techniques and antimicrobial susceptibility testing. Despite facing numerous challenges both prior to and during the trial, this RCT successfully recruited 2,000 participants within 11 months. This accomplishment can be attributed to the strong collaboration and teamwork exhibited throughout the process. The insights gained from this study may be of particular interest to researchers and scientists aiming to conduct investigations involving infants and children in low-income settings. Trial registrations This trial is registered with ClinicalTrials.gov, NCT04172012. November 21, 2019.
引用
- Moyo SJ, Justine M, Blomberg B, et al. Navigating the trials of a trial: lessons from ProRIDE on recruitment, retention, and follow-up in rural Africa. Trials. 2026. PMID: 41535953. doi:10.1186/s13063-026-09447-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。